Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer

• Autores principales: Alessandra I. G. Buma (Autor), Berber Piet (Autor), Rob ter Heine (Autor), Michel M. van den Heuvel (Autor), Paul Brinkman (Autor), Daan van den Broek (Autor), Sjaak Burgers (Autor), Francesco Ciompi (Autor), Simona M. Cristescu (Autor), Bram van Ginneken (Autor), Katrien Grünberg (Autor), Lizza Hendriks (Autor), Jeroen Hiltermann (Autor), Firdaus Mohamed Housein (Autor), Alwin Huitema (Autor), Jakko van Inge (Autor), Colin Jacobs (Autor), Hans Koenen (Autor), Marjolijn Ligtenberg (Autor), Anke H. Maitland-van der Zee (Autor), Vincent van der Noort (Autor), Mathias Prokop (Autor), Valesca Rètel (Autor), Heinrich Roder (Autor), Huub van Rossum (Autor), Ruben Smeets (Autor), Thomas Würdinger (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2023-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Personalization of treatment offers the opportunity to treat patients more effectively based on their dominant disease-specific features. The increasing number and types of treatment, and the high costs associated with these treatments, however, demand new approaches that improve patient selection w...